Atiprimod inhibits the growth of mantle cell lymphoma in vitro and in vivo and induces apoptosis via activating the mitochondrial pathways.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-11-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2006-12-063958PMID 17317853
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Atiprimod: a multi-functional drug candidate for myeloid and other malignancies.

  2007cited by this paper
• Atiprimod blocks phosphorylation of JAK-STAT and inhibits proliferation of acute myeloid leukemia (AML) cells.

  2007cited by this paper
• Loss of SOCS3 Gene Expression Converts STAT3 Function from Anti-apoptotic to Pro-apoptotic*

  2006cited by this paper
• Mantle cell lymphoma: an update on management.

  2006cited by this paper
• STAT3 is activated in a subset of the Ewing sarcoma family of tumours

  2006cited by this paper
• Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

  2006cited by this paper
• Activation of Stat3 in Primary Tumors from High-Risk Breast Cancer Patients Is Associated with Elevated Levels of Activated Src and Survivin Expression

  2006cited by this paper
• Current treatment approaches for mantle-cell lymphoma.

  2005cited by this paper
• Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells.

  2005cited by this paper
• Activation status of the JAK/STAT3 pathway in mantle cell lymphoma.

  2005cited by this paper
• Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, suppresses proliferation, and induces apoptosis in mantle cell lymphoma.

  2005cited by this paper
• Atiprimod blocks STAT3 phosphorylation and induces apoptosis in multiple myeloma cells

  2005cited by this paper
• High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.

  2005cited by this paper
• Azaspirane (N-N-diethyl-8,8-dipropyl-2-azaspiro [4.5] decane-2-propanamine) inhibits human multiple myeloma cell growth in the bone marrow milieu in vitro and in vivo.

  2005cited by this paper
• Biology and therapy of mantle cell lymphoma

  2005cited by this paper
• A clinically relevant SCID-hu in vivo model of human multiple myeloma.

  2004cited by this paper
• Comparison of Radiation Dose Estimation for Myeloablative Radioimmunotherapy for Relapsed or Recurrent Mantle Cell Lymphoma Using 131I Tositumomab to That of Other Types of Non-Hodgkin's Lymphoma

  2004cited by this paper
• New treatment strategies for multiple myeloma.

  2004cited by this paper
• Antitumor activity of rituximab plus thalidomide in patients with relapsed/refractory mantle cell lymphoma.

  2004cited by this paper
• Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.

  2004cited by this paper
• Inhibition of Constitutive NF-κB Activation in Mantle Cell Lymphoma B Cells Leads to Induction of Cell Cycle Arrest and Apoptosis1

  2003cited by this paper
• Inhibition of constitutive NF-kappa B activation in mantle cell lymphoma B cells leads to induction of cell cycle arrest and apoptosis.

  2003cited by this paper
• Expression of STAT3 and its phosphorylated forms in mantle cell lymphoma cell lines and tumours

  2003cited by this paper
• SeminarNon-Hodgkin lymphoma

  2003cited by this paper
• Non-Hodgkin lymphoma.

  2003cited by this paper
• Mitochondrial release of AIF and EndoG requires caspase activation downstream of Bax/Bak‐mediated permeabilization

  2003cited by this paper
• Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death

  2002cited by this paper
• Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma.

  2002cited by this paper
• The Bax Subfamily of Bcl2-Related Proteins Is Essential for Apoptotic Signal Transduction by c-Jun NH2-Terminal Kinase

  2002cited by this paper
• Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells

  2002cited by this paper
• Morphological spectrum of cyclin D1‐positive mantle cell lymphoma: Study of 168 cases

  2001cited by this paper
• Signal transduction by the JNK group of MAP kinases.

  2000cited by this paper
• [Mitochondria and apoptosis].

  2000cited by this paper
• Apoptosis‐inducing factor (AIF): a ubiquitous mitochondrial oxidoreductase involved in apoptosis

  2000cited by this paper
• Mitochondrio‐nuclear translocation of AIF in apoptosis and necrosis

  2000cited by this paper
• Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

  1999cited by this paper
• Stat3 as an oncogene.

  1999cited by this paper
• BCL-2 family members and the mitochondria in apoptosis.

  1999cited by this paper
• Molecular characterization of mitochondrial apoptosis-inducing factor

  1999cited by this paper
• BCL-2 Is Phosphorylated and Inactivated by an ASK1/Jun N-Terminal Protein Kinase Pathway Normally Activated at G2/M

  1999cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• Mitochondria and apoptosis.

  1998cited by this paper
• A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project.

  1997cited by this paper
• The clinical outcome of 65 cases of mantle cell lymphoma initially treated with non‐intensive therapy by the British National Lymphoma Investigation Group

  1997cited by this paper
• A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma: a report of the Non-Hodgkin's Lymphoma Classification Project

  1997cited by this paper
• Mantle cell lymphoma: a clinicopathologic study of 80 cases.

  1997cited by this paper
• HyperCVAD for VAD‐resistant multiple myeloma

  1996cited by this paper
• Bcl-2 inhibits the mitochondrial release of an apoptogenic protease

  1996cited by this paper
• Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L)

  1996cited by this paper
• New treatment strategies for multiple myeloma

  1990cited by this paper
• I kappa B: a specific inhibitor of the NF-kappa B transcription factor.

  1988cited by this paper
• Effective treatment of advanced multiple myeloma refractory to alkylating agents.

  1984cited by this paper
• The hematologic malignancies: Leukemia, lymphoma, and myeloma

  1984cited by this paper

• Apoptosis-inducing factor (AIF) at the crossroad of cell survival and cell death: implications for cancer and mitochondrial diseases

  2025cites this paper
• Scopoletin protects INS-1 pancreatic β cells from glucotoxicity by reducing oxidative stress and apoptosis.

  2023cites this paper
• The key players of parthanatos: opportunities for targeting multiple levels in the therapy of parthanatos-based pathogenesis

  2022cites this paper
• A Mini Review on Molecules Inducing Caspase-Independent Cell Death: A New Route to Cancer Therapy

  2022cites this paper
• IL-9/STAT3/fatty acid oxidation–mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity

  2022cites this paper
• Second-Generation Jak2 Inhibitors for Advanced Prostate Cancer: Are We Ready for Clinical Development?

  2021cites this paper
• JNK signaling as a target for anticancer therapy

  2021cites this paper
• MIF as a biomarker and therapeutic target for overcoming resistance to proteasome inhibitors in human myeloma.

  2020cites this paper
• JAK-STAT inhibitors: Immersing therapeutic approach for management of rheumatoid arthritis.

  2020cites this paper
• Parthanatos and its associated components: promising therapeutic targets for cancer.

  2020cites this paper
• Design and synthesis of novel xanthone-triazole derivatives as potential antidiabetic agents: α-Glucosidase inhibition and glucose uptake promotion.

  2019cites this paper
• Porphyromonas gingivalis degrades integrin β1 and induces AIF-mediated apoptosis of epithelial cells

  2019cites this paper
• Atiprimod induce apoptosis in pituitary adenoma: Endoplasmic reticulum stress and autophagy pathways

  2019influential citation
• Ginsenoside Re Ameliorates Brain Insulin Resistance and Cognitive Dysfunction in High Fat Diet-Induced C57BL/6 Mice.

  2017cites this paper
• Synthesis, characterization and anticancer activity of tanshinone I grafted low molecular chitosan

  2016cites this paper
• Role of AKT2 in Cell Survival, Establishment and/or Maintenance of Colorectal Cancer Metastasis

  2016cites this paper
• FV‐429 Induced Apoptosis Through ROS‐Mediated ERK2 Nuclear Translocation and p53 Activation in Gastric Cancer Cells

  2015cites this paper
• Pre-stimulation of CD81 expression by resting B cells increases proliferation following EBV infection, but the overexpression of CD81 induces the apoptosis of EBV-transformed B cells

  2015cites this paper
• Characteristics of human primary mantle cell lymphoma engraftment in NSG mice

  2015cites this paper
• Akt inhibitor MK-2206 promotes anti-tumor activity and cell death by modulation of AIF and Ezrin in colorectal cancer

  2014cites this paper
• Design, synthesis and biological evaluation of novel 1-hydroxyl-3-aminoalkoxy xanthone derivatives as potent anticancer agents.

  2014cites this paper
• Antibody ligation of CM1 on cisplatin-exposed HeLa cells induces apoptosis through reactive oxygen species-dependent Fas ligand expression.

  2014cites this paper
• Investigating the role of Class Ia phosphoinositide-3 kinase isoforms in Mantle Cell Lymphoma.

  2013cites this paper
• HQS-3, a newly synthesized flavonoid, possesses potent anti-tumor effect in vivo and in vitro.

  2013cites this paper
• The oxido-reductase activity of the apoptosis inducing factor: a promising pharmacological tool?

  2013cites this paper
• Role of STAT3 in Cancer Metastasis and Translational Advances

  2013cites this paper
• Mesenchymal stromal cells protect mantle cell lymphoma cells from spontaneous and drug-induced apoptosis through secretion of B-cell activating factor and activation of the canonical and non-canonical nuclear factor κB pathways

  2012cites this paper
• Anticancer action of garcinol in vitro and in vivo is in part mediated through inhibition of STAT-3 signaling.

  2012cites this paper
• Stat3 inhibition augments the immunogenicity of B-cell lymphoma cells, leading to effective antitumor immunity.

  2012cites this paper
• Combination of atiprimod and the proteasome inhibitor bortezomib induces apoptosis of mantle cell lymphoma in vitro and in vivo.

  2012cites this paper
• Innate Immunity and Resistance to Tolerogenesis in Allotransplantation

  2012cites this paper
• Role of apoptosis-inducing factor, proline dehydrogenase, and NADPH oxidase in apoptosis and oxidative stress.

  2012cites this paper
• Expression of AIF and HtrA2/Omi in small lymphocytic lymphoma and diffuse large B-cell lymphoma.

  2011cites this paper
• Reactive oxygen species–mitochondria pathway involved in FV-429-induced apoptosis in human hepatocellular carcinoma HepG2 cells

  2011cites this paper
• AIF‐mediated caspase‐independent necroptosis: A new chance for targeted therapeutics

  2011cites this paper
• Visible light may directly induce nuclear DNA damage triggering the death pathway in RGC-5 cells

  2011cites this paper
• Knock‐down of SOX11 induces autotaxin‐dependent increase in proliferation in vitro and more aggressive tumors in vivo

  2011cites this paper
• Antitumor Activity of Dichloromethane Extract from Salvia plebeia and Induction of Apoptosis on K 562 Cells

  2011cites this paper
• Reactive oxygen species-mitochondria pathway involved in LYG-202-induced apoptosis in human hepatocellular carcinoma HepG(2) cells.

  2010cites this paper
• Role of the microenvironment in mantle cell lymphoma: IL-6 is an important survival factor for the tumor cells.

  2010cites this paper
• Caspase-independent pathways of programmed cell death: the unraveling of new targets of cancer therapy?

  2009influential citation
• Dehydrocostuslactone disrupts signal transducers and activators of transcription 3 through up-regulation of suppressor of cytokine signaling in breast cancer cells

  2009cites this paper
• LYG-202, a new flavonoid with a piperazine substitution, shows antitumor effects in vivo and in vitro.

  2009cites this paper
• Dehydrocostuslactone, a Medicinal Plant-Derived Sesquiterpene Lactone, Induces Apoptosis Coupled to Endoplasmic Reticulum Stress in Liver Cancer Cells

  2009cites this paper
• The mitochondrial death pathway: a promising therapeutic target in diseases

  2009cites this paper
• HCCS1 overexpression induces apoptosis via cathepsin D and intracellular calcium, and HCCS1 disruption in mice causes placental abnormality

  2008cites this paper
• A Severe Combined Immunodeficient–hu In vivo Mouse Model of Human Primary Mantle Cell Lymphoma

  2008cites this paper
• Denbinobin induces apoptosis by apoptosis-inducing factor releasing and DNA damage in human colorectal cancer HCT-116 cells

  2008cites this paper
• Therapeutic potential of AIF-mediated caspase-independent programmed cell death.

  2007cites this paper